Key Takeaways:
Federal Circuit Reopens CRISPR-Cas9 Priority Fight. The CAFC vacated the PTAB’s earlier ruling that UC lacked prior conception of CRISPR-Cas9 in eukaryotic cells, remanding the interference for reconsideration...more
In its July 5, 2016 decision in Rapid Litigation Management Ltd and In Vitro, Inc. v. CellzDirect, Inc. and Invitrogen Corp., the Federal Circuit held that patent claims directed to an improved method of cryopreserving...more
7/9/2016
/ Ariosa ,
Biotechnology ,
CLS Bank v Alice Corp ,
Examiners ,
Life Sciences ,
Mayo v. Prometheus ,
Method Claims ,
Obviousness ,
Patent-Eligible Subject Matter ,
Patents ,
Petition for Writ of Certiorari ,
Reversal ,
Section 101 ,
Sequenom ,
Summary Judgment ,
USPTO